Condition: Crohn Disease · Sponsor: Children's Hospital Medical Center, Cincinnati
Approximately 3 million people in the United States are living with inflammatory bowel disease, which includes Crohn's Disease (CD). There are limited treatment options approved for use in children and adults with Crohn's disease. Physicians need better ways to inform decisions on treatment. The main reason for this research study is to determine if a computer program that calculates an individualized dose based on a patient's blood testing results (precision dosing) can better achieve the best possible response to infliximab compared to standard dosing (conventional dosing).
This description comes directly from the study's public registry record.
Phillip Minar, MD, MS · 513-636-4415 · phillip.minar@cchmc.org
Always discuss trial participation with your own doctor first.
| Children's Hospital of Los Angeles | Los Angeles, California, United States | Recruiting |
| Lucile Packard Children's Hospital Stanford | Palo Alto, California, United States | Recruiting |
| Rady Children's Hospital San Diego | San Diego, California, United States | Recruiting |
| Nemours Children's Health System-Wilmington | Wilmington, Delaware, United States | Recruiting |
| Nemours Children's Health System-Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Riley Hospital for Children | Indianapolis, Indiana, United States | Recruiting |
| Cincinnati Children's Hospital | Cincinnati, Ohio, United States | Recruiting |
| Cleveland Clinic Children's Hospital | Cleveland, Ohio, United States | Recruiting |
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
| Children's Specialty Group | Norfolk, Virginia, United States | Recruiting |
| Medical College of Wisconsin, Children's of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05660746